Health ❯ Healthcare ❯ Cancer ❯ Prostate Cancer

PSA Testing

UK Advisers Reject Population Prostate Screening and Limit Tests to BRCA2 Carriers

Modelling found PSA testing causes more overdiagnosis and harm than overall benefit for the general population.

Cochrane Review Finds PSA Screening Modestly Cuts Prostate Cancer Deaths